Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenesis inhibitors. New anticancer strategy.

W Zgodziński1, G Wallner, A Dabrowski

  • 12nd Department of General Surgery, University School of Medicine in Lublin, Poland.

Polish Journal of Pharmacology
|May 19, 2000
PubMed
Summary

This review explores angiogenesis inhibitors, focusing on factors that block tumor blood vessel formation. These compounds show promise as novel anticancer drugs currently in clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Inelastic Dark Matter in Events with Two Displaced Muons and Missing Transverse Momentum in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2024
Same author

Evidence for the Higgs Boson Decay to a Z Boson and a Photon at the LHC.

Physical review letters·2024
Same author

Probing Small Bjorken-x Nuclear Gluonic Structure via Coherent J/ψ Photoproduction in Ultraperipheral Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2024
Same author

Measurement of the top quark mass using a profile likelihood approach with the lepton + jets final states in proton-proton collisions at <math></math>.

The European physical journal. C, Particles and fields·2023
Same author

Observation of τ Lepton Pair Production in Ultraperipheral Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2023
Same author

A search for decays of the Higgs boson to invisible particles in events with a top-antitop quark pair or a vector boson in proton-proton collisions at <math></math>.

The European physical journal. C, Particles and fields·2023

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Neoangiogenesis is vital for tumor growth and metastasis.
  • Factors influencing tumor vascularization include pro-angiogenic and anti-angiogenic agents.
  • The therapeutic potential of suppressing tumor vasculature is under active research.

Purpose of the Study:

  • To review the primary categories of angiogenesis inhibitors.
  • To elucidate their distinct mechanisms of action.
  • To present data from ongoing clinical studies.

Main Methods:

  • Literature review of angiogenesis inhibitors.
  • Analysis of their molecular targets and pathways.
  • Compilation of clinical trial outcomes.

Main Results:

  • Identification of key angiogenesis inhibitor classes.
  • Description of their diverse mechanisms, such as TNP-470 and MMP inhibitors.
  • Summary of clinical efficacy and safety data.

Conclusions:

  • Angiogenesis inhibitors represent a significant therapeutic strategy in oncology.
  • Further clinical investigation is essential to optimize their use in cancer treatment.
  • Targeting tumor vasculature offers a promising avenue for novel anticancer drug development.

Related Experiment Videos